Management of a patient with schizophrenia associated with Crohn's disease: case report
DOI:
https://doi.org/10.25118/2763-9037.2024.v14.1360Keywords:
Comorbidity, Crohn's disease, Drug Therapy, schizophrenia, referral and consultationAbstract
Introduction: Schizophrenia is a psychiatric illness characterized by cognitive, affective and psychotic disorders, being one of the most serious mental disorders with social and psychological impact. Method: Case report. Associação Evangélica Beneficiente de Londrina, AEBEL. Approval Research Ethics Committee (REC) n. 7.122.704. Case presentation: This article describes the case of a patient diagnosed with paranoid schizophrenic disorder and suffering from serious medical comorbidities. The patient presented psychotic symptoms with auditory hallucinations, persecutory delusions and disorganized behavior when he sought the city's psychiatric hospital. Despite regular monitoring at the Psychosocial Care Center (CAPS) and the use of conventional antipsychotic medications, there was no significant improvement in symptoms. During hospitalization, compromised gastrointestinal absorption was diagnosed due to the progression of Crohn's disease, which influenced the choice of drug therapy. Multidisciplinary treatment was crucial for a comprehensive approach to the patient. Result: The introduction of injectable depot medication, such as Zuclopenthixol (Clopixol Depot®), demonstrated a substantial improvement in psychotic symptoms, indicating the importance of concomitant medical conditions in the management of schizophrenia. Conclusion: The clinical management of patients with schizophrenia and severe medical comorbidities requires an integrated and individualized approach. Consideration of concomitant medical conditions, along with assessment of psychiatric symptoms, is essential for therapeutic success.
Downloads
Metrics
References
Orsi P, Lazzarin MAL, Sammour J, Silva MHP, Zonetti IO, Ribeiro AL, Eleutério RF, Faria BA, Alvarenga AC, Brito NEP, Silva LA, Aros MS. Esquizofrenia: manifestações clínicas e as principais comorbidades, uma revisão sistemática. Braz J Health Rev. 2024;7(2):e69158. https://doi.org/10.34119/bjhrv7n2-431 DOI: https://doi.org/10.34119/bjhrv7n2-431
Queirós T, Coelho F, Linhares L, Telles-Correia D. Esquizofrenia: o que o médico não psiquiatra precisa de saber. Acta Med Port. 2019;32(1):70-7. https://doi.org/10.20344/amp.10768 PMID:30753806 DOI: https://doi.org/10.20344/amp.10768
Fulone I, Silva MT, Lopes LC. Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil. BMC Psychiatry. 2021;21:320. https://doi.org/10.1186/s12888-021-03327-7 PMID:34187418 - PMCID:PMC8243572 DOI: https://doi.org/10.1186/s12888-021-03327-7
Fulone I, Silva MT, Lopes LC. Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017. Epidemiol Serv Saude. 2023;32(1):e2022556. https://doi.org/10.1590/s2237-96222023000300015 PMID:36946832 - PMCID:PMC10072313 DOI: https://doi.org/10.1590/S2237-96222023000300015
American Psychiatric Association. Manual diagnóstico e estatístico de transtornos mentais: DSM-5. 5. ed. Porto Alegre: Artmed; 2014.
Baêta OM, Alves AK, Moreno JM, Silva JRF, Souza MLF, Sobral RB, Pissinatti RS, Paixão VC, Vieira VBT, Tafner V. Doença de Crohn - uma revisão abrangente sobre a epidemiologia, fisiopatologia e patogênese, fatores de risco, diagnóstico clínico, diagnóstico imagiológico, manifestações extra intestinais, tratamento, nutrição e dieta. Braz J Health Rev. 2023;6(4):17438-54. https://doi.org/10.34119/bjhrv6n4-265 DOI: https://doi.org/10.34119/bjhrv6n4-265
National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management. London: National Institute for Health and Care Excellence; 2014. https://www.nice.org.uk/guidance/cg178
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2024 Fausto Tatsuo Ochiro, André Ferreira Dias, Guilherme Pelissari Vieira
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
